NCT02352623

Brief Summary

Health-related Quality of life in Danish stage IB-III cutaneous melanoma patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
435

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 19, 2015

Completed
13 days until next milestone

Study Start

First participant enrolled

February 1, 2015

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 2, 2015

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2016

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2016

Completed
Last Updated

May 26, 2016

Status Verified

May 1, 2016

Enrollment Period

1 year

First QC Date

January 19, 2015

Last Update Submit

May 25, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Global Health Score

    Quality of life will be assessed with the questionnaire EORTC QLQ-C30 v.3.0

    12 months

Secondary Outcomes (5)

  • Anxiety

    12 months

  • Depression

    12 months

  • Lymphoedema

    12 months

  • Neuropathic pain

    12 months

  • Volume and tissue composition assessed with DXA scan

    12 months

Study Arms (1)

Cutaneous melanoma AJCC stage IB-III

Patients treated for cutaneous melanoma (AJCC stage IB-III) will fill out a questionnaire, undergo clinical examination and DXA scan

Radiation: DXA scanProcedure: Clinical examination

Interventions

DXA scanRADIATION

DXA scan

Cutaneous melanoma AJCC stage IB-III

Clinical examination

Cutaneous melanoma AJCC stage IB-III

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients treated for cutaneous melanoma (AJCC stage IB-III) with wide local excision (WLE) and sentinel lymph node biopsy (SNB) and/ or complete lymph node dissection in the axilla and/or groin will be included in the study.

You may qualify if:

  • AJCC stage IB-III cutaneous melanoma patients
  • At least one year follow-up after melanoma surgery

You may not qualify if:

  • Pregnancy
  • Bilateral axilla or groin melanoma surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Plastic Surgery, Herlev Hospital

Herlev, 1815, Denmark

Location

Related Publications (1)

  • Gjorup CA, Groenvold M, Hendel HW, Dahlstroem K, Drzewiecki KT, Klausen TW, Holmich LR. Health-related quality of life in melanoma patients: Impact of melanoma-related limb lymphoedema. Eur J Cancer. 2017 Nov;85:122-132. doi: 10.1016/j.ejca.2017.07.052. Epub 2017 Sep 15.

MeSH Terms

Conditions

MelanomaLymphedemaDepressionAnxiety DisordersPainCicatrix

Interventions

Absorptiometry, PhotonRestraint, Physical

Condition Hierarchy (Ancestors)

Neuroendocrine TumorsNeuroectodermal TumorsNeoplasms, Germ Cell and EmbryonalNeoplasms by Histologic TypeNeoplasmsNeoplasms, Nerve TissueNevi and MelanomasSkin NeoplasmsNeoplasms by SiteSkin DiseasesSkin and Connective Tissue DiseasesLymphatic DiseasesHemic and Lymphatic DiseasesBehavioral SymptomsBehaviorMental DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsFibrosisPathologic Processes

Intervention Hierarchy (Ancestors)

RadiographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisDensitometryPhotometryChemistry Techniques, AnalyticalInvestigative TechniquesBehavior ControlTherapeuticsImmobilization

Study Officials

  • Caroline Asirvatham Gjørup, MD

    Department of Plastic Surgery

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D. ph.d. student

Study Record Dates

First Submitted

January 19, 2015

First Posted

February 2, 2015

Study Start

February 1, 2015

Primary Completion

February 1, 2016

Study Completion

May 1, 2016

Last Updated

May 26, 2016

Record last verified: 2016-05

Locations